Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02520427 |
Title | A Phase 1 Study of AMG 330 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia |
Recruitment | Terminated |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Amgen |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | NLD | DEU | CAN |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Alabama at Birmingham | Birmingham | Alabama | 35294-3300 | United States | Details | |
Research Site | Duarte | California | 91010 | United States | Details | |
Wake Forest University Health Sciences | Winston-Salem | North Carolina | 27157 | United States | Details | |
University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
Seattle Cancer Care Alliance | Seattle | Washington | 98109 | United States | Details | |
Princess Margaret Cancer Centre | Toronto | Ontario | M5G 2M9 | Canada | Details | |
Universitätsklinikum Schleswig-Holstein | Kiel | 24105 | Germany | Details | ||
Klinikum der Universität München Campus Grosshadern | München | 81377 | Germany | Details | ||
Universitatsklinikum Ulm | Ulm | 89081 | Germany | Details | ||
Research Site | Amsterdam | 1007 MB | Netherlands | Details | ||
Erasmus Medisch Centrum | Rotterdam | 3015 CE | Netherlands | Details |